Medline Reports Third Quarter and Nine Months 2026 Results
Article excerpt
Highlighted: the sentence this signal was extracted from
NORTHFIELD, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (Nasdaq: MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care 3, today reported its operating results for the three and nine months ended September 26, 2026. "Medline delivered another strong quarter, with double-digit net sales growth, reflecting continued momentum across our business," said Jim Boyle, chief executive officer of Medline. "Our commercial execution remains strong, including continued progress toward our annual total new customer signings 4 goal. We are advancing key strategic priorities, including capacity expansion and new technology across our distribution network and progress with our global quality initiatives. We remain focused on serving our customers, advancing our strategic priorities and driving sustainable long-term growth." Third Quarter 2026 Results Third quarter 2026 net sales increased 10.4% to $7.9 billion, compared to $7.1 billion in the third quarter 2025, with Organic Sales¹ increasing 10.5%. This was primarily driven by existing customer growth and implementation of new customer signings from 2025 and includes an $11 million increase related to an adjustment of customer repayment amounts. Third quarter 2026 net income decreased 1.2% to $318 million, compared to $322 million in...
Keep reading with a free account
The rest of this article, and every signal for Medline, is in your free account.